Document:

Exhibit 10.4.4

 

THIRD
AMENDMENT TO

EMPLOYMENT
AGREEMENT

 

THIS THIRD
AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”) is entered into as of this
9th day of January, 2006 by and between A.D.A.M., Inc., a Georgia
corporation (the “Company”) and Kevin S. Noland, an individual resident of the
State of Georgia (“Employee”).

 

RECITALS:

 

                WHEREAS, the Company and Employee entered into that
certain Employment Agreement, dated as of February 21, 2002, as amended by a
First Amendment to Employment Agreement dated March 14, 2005 and a Second
Amendment to Employment Agreement dated October 3, 2005 (the “Original
Employment Agreement”); and

 

                WHEREAS, the parties wish to make certain amendments
to certain provisions of the Original Employment Agreement and to memorialize
such amendments hereby;

 

                NOW, THEREFORE, in consideration of the foregoing
Recitals and the mutual agreements and covenants contained herein, and for
other good and valuable consideration, the receipt and sufficiency of which
hereby are acknowledged, the parties hereto hereby agree as follows:

 

1.             The second Recital of the Original
Employment Agreement is hereby deleted in its entirety and replaced with the
following language:

 

“WHEREAS, the
Company desires to employ the Employee as its President and Chief Executive
Officer (“CEO”), and Employee desires to accept such employment with the
Company, all in accordance with the terms and conditions hereinafter set forth;”

 

2.             Section 1 of the Original
Employment Agreement is hereby deleted in its entirety and replaced with the
following language:

 

“1.           Employment
and Duties.

 

(a)           Subject to the terms and conditions
set forth in this Agreement, the Company hereby agrees to employ the Employee,
and the Employee hereby agrees to serve the Company, as the CEO of the Company.
In performing his duties hereunder, the Employee shall report to and be
directly responsible to the Board of Directors of the Company.

 

(b)           During the term of this Agreement,
the Employee shall, for the benefit of the Company, use his skills, knowledge,
and specialized training to perform the duties and exercise the powers,
functions, and discretion incident to his position as CEO of the Company or
which from time to time, consistent with such position, may be assigned to or
vested in him by the Board of Directors, in an efficient and competent manner
and on such terms and subject to such restrictions as the Board of Directors
may from time to time impose.

 

 

(c)           During the term of this Agreement,
the Employee shall perform his duties hereunder at the Company’s then current
headquarters or as otherwise directed by the Board of Directors from time to
time.

 

(d)           During the term of this Agreement,
the Employee agrees to devote his full business time, energy, and skill to the
business of the Company, and to the fulfillment of the Employee’s obligations
under this Agreement. In addition to the foregoing and not in limitation
thereof, during the term hereof, the Employee shall not carry on, engage in, or
otherwise be interested in, directly or indirectly, any other business or
activity that would result in a conflict of interest with the Company’s
business or that would materially adversely affect the Employee’s ability to
perform his duties as set forth in this Agreement.”

 

3.             The words “CEO or” are hereby
deleted from Sections 3(a) and 6(g) of the Original Employment Agreement.

 

4.             This Amendment may be executed in
counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument.

 

5.             Except as set forth above, the
Original Employment Agreement shall continue as set forth immediately prior to
the effectuation of the amendments set forth herein, and by its execution
hereof, each of the parties hereto hereby confirms its agreement to the terms of
the Original Employment Agreement as amended hereby.

 

 

IN
WITNESS WHEREOF,
the parties hereto have executed this Amendment as of the date first written
above.

 

	
   

  	
   

  	
  THE
  COMPANY

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  A.D.A.M.,
  INC.

  
	
   

  	
   

  	
  By: /s/ Francis J. Tedesco

  
	
   

  	
   

  	
  Francis J. Tedesco

  
	
   

  	
   

  	
  Chairman, Compensation Committee of the Board of
  Directors

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  EXECUTIVE

  
	
   

  	
   

  	
  /s/ Kevin S. Noland

  
	
   

  	
   

  	
  Kevin S. NolandExhibit 10.32

 

BIOSANTE PHARMACEUTICALS, INC.

 

DESCRIPTION OF NON-EMPLOYEE DIRECTOR

COMPENSATION ARRANGEMENTS

 

 

Retainer and Meeting Fees. Except as described below, each of our
non-employee directors is paid a $20,000 annual retainer and $1,000 for each board
or committee meeting attended in person and $500 for each board or committee
meeting attended via telephone. Our Chairman of the Board is paid a $45,000
annual retainer and our Chairman of the Audit and Finance Committee is a paid a
$25,000 annual retainer.

 

Stock Options. Non-employee directors are granted options
to purchase shares of BioSante common stock from time to time in the sole
discretion of the board of directors.

 

Reimbursement of Expenses. Non-employee directors are reimbursed for
actual expenses, include travel expenses, incurred in attending board and
committee meetings.Exhibit 10.33

 

BIOSANTE PHARMACEUTICALS, INC.

 

DESCRIPTION OF EXECUTIVE OFFICER

COMPENSATION ARRANGEMENTS

 

BioSante Pharmaceuticals, Inc. has entered into employment
agreements with each of its executive officers, copies of which agreements have
been filed with the Securities and Exchange Commission, as exhibits to BioSante’s
annual report on Form 10-K. The following is a description of oral
amendments to those employment agreements or additional oral compensation
arrangements between BioSante and the following executive officers of BioSante:

 

	
  Name of

  Executive

  Officer

  	
   

  	
  Title

  	
   

  	
  Base

  Salary

  	
   

  	
  Bonus

  Arrangements

  	
   

  	
  Stock

  Options

  	
   

  	
  Other

  
	
  Stephen
  M. Simes

  	
   

  	
  Vice
  Chairman, President and Chief Executive Officer

  	
   

  	
  $374,400
  per year.

  	
   

  	
  $60,000
  for the year ended December 31, 2004 paid in January 2006.

  	
   

  	
  Stock
  options to purchase shares of BioSante common stock are granted from time to
  time in the sole discretion of the Compensation Committee of the BioSante
  Board of Directors.

  	
   

  	
  Under
  the BioSante Pharmaceuticals, Inc. 401(k) Savings Plan, participants,
  including executive officers, may voluntarily request that BioSante
  reduce pre-tax compensation by up to 100% (subject to certain special
  limitations) and contribute such amounts to a trust. BioSante contributed an
  amount equal to 50% of the amount that each participant contributed under
  this plan.

  

  Executive officers receive other benefits received by other BioSante
  employees, including health, dental and life insurance benefits. Executive
  officers also receive an auto allowance.

  
Mr. Simes also receives reimbursement for excess long-term
  disability and excess life insurance premiums and taxes associated with the
  premiums.

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Phillip
  B. Donenberg

  	
   

  	
  Chief
  Financial Officer, Treasurer and Secretary

  	
   

  	
  $208,572
  per year.

  	
   

  	
  $150,000
  for the year ended December 31, 2005 paid in March 2006 and $25,500
  for the year ended December 31, 2004 paid in January 2006.

  	
   

  	
  On
  March 16, 2006, the Compensation Committee of the BioSante Board of
  Directors granted Mr. Donenberg an option to purchase 62,500 shares of
  BioSante common stock at an exercise price of $3.87 per share. Such option
  vests in three equal (or as nearly equal as possible) yearly installments,
  with the first installment beginning on the one-year anniversary of the date
  of grant.

  	
   

  	
  Under
  the BioSante Pharmaceuticals, Inc. 401(k) Savings Plan, participants,
  including executive officers, may voluntarily request that BioSante
  reduce pre-tax compensation by up to 100% (subject to certain special
  limitations) and contribute such amounts to a trust. BioSante contributed an
  amount equal to 50% of the amount that each participant contributed under
  this plan.

  

  Executive officers receive other benefits received by other BioSante
  employees, including health, dental and life insurance benefits. Executive
  officers also receive an auto allowance.

  

 

 

	
  Name of

  Executive

  Officer

  	
   

  	
  Title

  	
   

  	
  Base

  Salary

  	
   

  	
  Bonus

  Arrangements

  	
   

  	
  Stock

  Options

  	
   

  	
  Other

  
	
  Steven
  J. Bell, Ph.D.

  	
   

  	
  Vice
  President, Research and Pre-Clinical Development

  	
   

  	
  $174,720
  per year.

  	
   

  	
  $35,000
  for the year ended December 31, 2005 paid in March 2006 and $16,000
  for the year ended December 31, 2004 paid in January 2006.

  	
   

  	
  Stock
  options to purchase shares of BioSante common stock are granted from time to
  time in the sole discretion of the Compensation Committee of the BioSante
  Board of Directors.

  	
   

  	
  Under
  the BioSante Pharmaceuticals, Inc. 401(k) Savings Plan, participants,
  including executive officers, may voluntarily request that BioSante
  reduce pre-tax compensation by up to 100% (subject to certain special
  limitations) and contribute such amounts to a trust. BioSante contributed an
  amount equal to 50% of the amount that each participant contributed under
  this plan.

  

  Executive officers receive other benefits received by other BioSante
  employees, including health, dental and life insurance benefits. Executive
  officers also receive an auto allowance.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00101-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00101-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00101-of-00352.parquet"}]]